Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitroethane SCHEMBL35035 | 0.86 | — | — | |
| Nitroethane SCHEMBL1332217 | 0.86 | — | — | |
| Nitroethane SCHEMBL11203503 | 0.83 | — | — | |
| Nitroethane SCHEMBL11366611 | 0.83 | — | — | |
| Nitroethane SCHEMBL7774447 | 0.82 | — | — | |
| Nitroethane SCHEMBL27939198 | 0.82 | — | — | |
| Nitroethane SCHEMBL29866506 | 0.82 | — | — | |
| Nitroethane SCHEMBL27781345 | 0.82 | — | — | |
| Nitroethane SCHEMBL27907184 | 0.80 | — | — | |
| Nitroethane SCHEMBL1011599 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752133-A1 | SUSTAINED RELEASE FORMULATIONS OF BEMPEDOIC ACID | Esperion Therapeutics, Inc. (US) | 2020-12-23 | — | — | EP | disclosed |
| WO-2019161307-A1 | SUSTAINED RELEASE FORMULATIONS OF BEMPEDOIC ACID | ESPERION THERAPEUTICS, INC. (US) | 2019-08-22 | — | — | WO | disclosed |
| CN-108354930-A | Include the pharmaceutical preparation of 1- (β-D- glucopyranosyls) -2- thienyl-methyl benzene derivatives | 詹森药业有限公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-106983744-A | Conjoint therapy for treating diabetes | 詹森药业有限公司 | 2017-07-28 | — | — | CN | disclosed |
| US-9393192-B2 | Methods and dosage forms for controlled delivery of paliperidone and risperidone | ALZA CORPORATION | 2016-07-19 | — | — | US | disclosed |
| CN-103800300-A | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | ALZA CORP | 2014-05-21 | — | — | CN | disclosed |
| US-20140044782-A1 | CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS | ALZA CORPORATION (US) | 2014-02-13 | — | — | US | disclosed |
| CN-1957909-B | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | ALZA CORP | 2013-09-11 | — | — | CN | disclosed |
| US-20130209525-A1 | CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS | ALZA CORPORATION (US) | 2013-08-15 | — | — | US | disclosed |
| EP-1951232-B1 | METHODS OF REDUCING ALCOHOL-INDUCED DOSE DUMPING FOR OPIOID SUSTAINED RELEASE ORAL DOSAGE FORMS | ALZA CORP (US) | 2013-04-03 | — | — | EP | disclosed |
| EP-1126853-A1 | CONTROLLED DELIVERY OF ANTIDEPRESSANTS | ALZA CORPORATION (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1126827-A2 | CONTROLLED DELIVERY OF ACTIVE AGENTS | ALZA CORPORATION (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001019337-A2 | DOSAGE FORMS AND METHODS FOR PROVIDING EFFECTIVE REBOXETINE THERAPY WITH ONCE-A-DAY DOSING | ALZA CORPORATION (US) | 2001-03-22 | — | — | WO | disclosed |
| US-6096339-A | Dosage form, process of making and using same | ALZA CORPORATION (US) | 2000-08-01 | — | — | US | disclosed |
| WO-2000038655-A1 | DOSAGE FORMS COMPRISING POROUS PARTICLES | ALZA CORPORATION (US) | 2000-07-06 | — | — | WO | disclosed |
| WO-2000025753-A2 | CONTROLLED DELIVERY OF ACTIVE AGENTS | ALZA CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000025790-A1 | CONTROLLED DELIVERY OF ANTIDEPRESSANTS | ALZA CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |
| EP-0907358-A2 | UNIFORM DRUG DELIVERY THERAPY | ALZA CORPORATION (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997037640-A2 | UNIFORM DRUG DELIVERY THERAPY | ALZA CORPORATION (US) | 1997-10-16 | — | — | WO | disclosed |
| US-5413572-A | Osmotic dosage system for liquid drug delivery | ALZA CORPORATION (US) | 1995-05-09 | — | — | US | disclosed |